Giuseppe Ciccotosto

Senior Research Fellow

University of Melbourne
Country flagAustralia
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (1)

Autophagy is a highly-conserved mechanism that ensures the lysosomal degradation of disposable or potential toxic cytosolic entities in support of cell survival and adaptation to stress. Autophagy is deregulated in various pathological conditions including cardiovascular, neurological, neoplastic-autoimmune and degenerative disorders. However, clinically relevant pharmacological modulators of autophagy remain elusive, calling for the development of novel screening approaches that are amenable to high throughput/content applications. Here, we describe a simple method to detect autophagy in cultured mammalian cells based on the pH-sensitive fluorescent conjugate CalRexin™:pHrodo™ Red and high throughput/content imaging. CalRexin™:pHrodo™ Red is promptly taken up by endosome-amphisome-autolysosome (low pH ∼4.5) pathway, which is connected to canonical autophagy, culminating with a bright red fluorescence. Importantly, this system allows for the discrimination between autophagic responses coupled with the endosome-amphisome-autolysosome pathways and the endosome-lysosome pathway as elicited by receptor-driven endocytosis and phagocytosis. In human cervical carcinoma sHeLa cells, the accumulation of CalRexin™:pHrodo™ Red as elicited by canonical autophagy activators like the mTOR inhibitor rapamycin or serum starvation was suppressed by conventional inhibitors 3-methyladenine or chloroquine. Similarly, RB1CC1-/-(FIP200) as well as ATG5-/- sHeLa cells (which bear genetic defects in two different steps of autophagy) were unable to accumulate CalRexin™:pHrodo™ Red upon exposure to autophagy activators. Thus, CalRexin™:pHrodo™ Red provides a novel approach for imaging autophagy on high throughout/content platforms to screen large libraries for the identification of novel autophagy-targeting agents.

Year:

2025

Collaborators (5)

David Linley Hare

University of Melbourne

AUSTRALIA
View details

Michael Lazarou

MONASH UNIVERSITY

AUSTRALIA
View details

Sebastian Furness

Future Fellow / Senior Research Fellow

MONASH UNIVERSITY

AUSTRALIA
View details

Peter Wookey

Founder/Director/Chief Scientific Officer

Apop Biosciences Pty Ltd

AUSTRALIA
View details

Lorenzo Galluzzi

-

UNITED STATES
View details